Alvotech Shares Jump after FDA Accepts Entyvio Biosimilar Application for Review (alvo)
Alvotech (NASDAQ:ALVO) shares climbed 12% in premarket trading on Thursday after the biotechnology company announced that the U.S. Food and Drug Administration has accepted its Biologics License Application for AVT16, an interchangeable biosimilar candidate to Entyvio